Serum

Serum Institute of India Private Limited develops and manufactures essential immunobiologicals, standing as the world's largest vaccine producer by volume. The company employs advanced genetic and cell-based technologies, creating a diverse portfolio including vaccines for Polio, Diphtheria, Tetanus, Measles, and Covid-19. Its robust capabilities deliver high-quality, life-saving biologicals to global markets.

Dr. Cyrus Poonawalla founded Serum Institute in 1966. He was driven by the critical need to address shortages and high costs of imported life-saving immunobiologicals in India. His insight led to establishing the enterprise with a philanthropic aim: achieving national self-sufficiency in vaccine production and making these essential medicines affordable. This founding vision continues to guide the company's operational philosophy.

The company's products reach an extensive global demographic, with approximately 65% of the world's children receiving at least one Serum Institute vaccine. These are integral to national immunization programs across 170 countries. Serum Institute's mission is to proliferate its philanthropic philosophy, ensuring affordable access to vaccines and protecting underprivileged children worldwide, contributing substantially to global disease eradication.